jain.com

Charter Amendment - Increase Authorized Common Stock

Company: TeraWulf

This claim was marked delayed on September 3, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
financing
Statement date
2025-09-07
Promised by
2025-09-30
Promised amount
950000000.0 shares
Current status
delayed

The claim, verbatim

Seeking stockholder approval to amend the Certificate of Incorporation to increase authorized common stock from 600,000,000 shares to 950,000,000 shares

Source (primary)

TeraWulf DEF 14A filed 2025-09-08 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗

Quote: “To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, par value $0.001 per share ("Common Stock"), authorized for issuance from 600,000,000 shares to 950,000,000 shares”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms TeraWulf DEF 14A filed 2025-09-08

Quote: “To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, par value $0.001 per share ("Common Stock"), authorized for issuance from 600,000,000 shares to 950,000,000 shares”

View cached copy (2026-08-31)Live source ↗

Record of changes

September 2, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 3, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.